Annual report pursuant to Section 13 and 15(d)

Basis of Presentation and Liquidity (Details)

v3.19.1
Basis of Presentation and Liquidity (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 2 Months Ended 9 Months Ended 12 Months Ended
Mar. 12, 2018
Mar. 31, 2018
Oct. 31, 2017
Sep. 30, 2017
Feb. 28, 2018
Dec. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Mar. 29, 2017
Cash and cash equivalents           $ 887 $ 42,565 $ 887  
Working capital             38,500    
Total stockholders deficit and net Parent investment           (982) 38,889 (982) $ (314)
Net cash used in operating activities             (13,509) (2,196)  
Net loss           (4,010) (19,270) (4,539)  
Number of shares issued     271,839 155,709 283,452        
Purchase price (in dollar per share)     $ 4.82 $ 4.82 $ 6.88        
Proceeds from issuance of common stock, net     $ 1,310 $ 751 $ 1,950   $ 56,513 2,061  
Underwriting discounts and commissions   $ 4,200              
Deferred offering expenses           $ 461   $ 461  
IPO                  
Number of shares issued 5,454,545                
Purchase price (in dollar per share) $ 11.00                
Gross proceeds from issuance of common stock $ 60,000                
Proceeds from issuance of common stock, net 54,102                
Underwriting discounts and commissions 4,200                
Deferred offering expenses $ 1,698